Insights, tips and industry commentary from the team behind the world’s first production-grade open source risk management platform.

Jonathan Senior

Introducing OpenGamma’s next-generation market risk library

The OpenGamma Platform was launched in 2011 to provide standardised models and market risk functionality to the industry, as open source software. It was designed to support a range of use-cases, and many people we engaged with saw its potential in solving both buy-side and sell-side risk requirements.

The deadline for CAT 2 frontloading is fast approaching: have you quantified the impact of clearing?

The frontloading deadline for Category 2 OTC clearing (21 May) is just around the corner, prompting many to start anlaysing the most cost-effective way to cope with this new requirement. 

As the provider of margin calculation software to both CCPs and Tier 1 banks, we are uniquely placed to help asset managers prepare for OTC Clearing. Here’s a great example of how we have just helped one of our investment management clients to work out the true cost of clearing.

Our new hosted service makes margining analysis accessible for all

With regulation driving derivatives trading firms to make decisions on their approach to mandatory OTC clearing, they will be weighing up CCPs’ competing claims about potential cost savings that can be derived from cross-margining. However, attempting to separate the hype from the reality can be difficult, while at the same time potentially significant given the possibility of up to 35% reduction on the hundreds of millions of dollars in initial margin posted by even medium sized firms.

Marc Henrard

Your questions answered: new Q&A available on our MVA research

We’ve received a number of follow-up questions on the back of the research paper on MVA we published last month in collaboration with University College London.

We’ve provided answers to the questions below, and will continue to update with answers to your questions as they come in.  Please send your questions to Marc Henrard.

Results of our margining survey

In our last newsletter we asked readers to participate in a survey on margining. This produced some interesting results in regard to trends we see gaining momentum in the market in the near future: the rise of lifetime initial margin calculations, and an increasing need for independent CCP model implementation.

Marc Henrard

New OpenGamma research with UCL supports practical solutions for MVA

As the market is well aware, initial margin will be charged on both cleared and non-cleared OTC (for large dealers by Sep 2016). This ties up large amounts of high quality collateral which in turn creates a significant funding and capital costs for holding OTC positions. Initial margins will be charged by the CCP daily for the full holding period of the trade (potentially to maturity) and it is this long-term nature of initial margin that makes these costs difficult to estimate.

Let’s be clear: Margining is no longer just a sell-side headache

When the deadline for regulatory compliance was extended to Q4 2016, many buy-side firms may have gratefully shelved any nascent worries about OTC derivatives clearing.

OpenGamma Margining: or, How to optimize your OTC CCP margin buffer

A leading bank has created a central margin calculation utility for OTC Clearing powered by OpenGamma to address a number of requirements. This case study shows how they did it.

Overview: The bank currently runs a margin buffer at the CCPs where most of their client swaps are cleared. The buffer is in place to facilitate client intraday trading where a client will post margin post execution of the trade.

Kirk Wylie

The Full Story of the OpenGamma/Eurex Clearing Partnership

How smarter IM calculation can minimize capital allocation

A common challenge for our customers is the substantial amount of capital consumed by the clearing process. A particular frustration is the funding costs associated with posting Initial Margin to the clearing houses for the entire life of the trades.